Description
Selectively and reversibly blocks MAGL activity (IC50s = 0.18 and 59 µM for MAGL and FAAH in mouse brain, respectively); does not inhibit ABHD6, ABHD12, CB1, or CB2 receptors (Kis > 10 µM); used to ameliorate disease progression in a mouse model of multiple sclerosis
Formal name: [1,1’-biphenyl]-4-hexanoic acid, 1,3-benzodioxol-5-ylmethyl ester
Synonyms: MAGL Inhibitor 21|MGL Inhibitor 21
Molecular weight: 402.5
CAS: 1643657-35-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Glycerolipid Lipases||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids